Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia

INTRODUCTION: Acute myeloblastic leukaemia (AML) constitutes the second most common haematological malignancy in the paediatric population. Current treatment regimens are based on the administration of polychemotherapy, combining high doses of cytarabine with anthracyclines and topoisomerase inhibit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open
Main Authors: Muñoz Builes, Mario, Vela Cuenca, María, Fuster Soler, Jose L, Astigarraga, Itziar, Pascual Martínez, Antonia, Vagace Valero, Jose M, Tong, Hoi Y, Valentín Quiroga, Jaime, Fernández Casanova, Lucía, Escudero López, Adela, Sisinni, Luisa, Blanquer, Miguel, Mirones Aguilar, Isabel, González Martínez, Berta, Borobia, Alberto M, Pérez-Martínez, Antonio
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Haematology (Incl Blood Transfusion)
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6955478/
https://ncbi.nlm.nih.gov/pubmed/31919123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-029642
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados